Cambodia purchases 4 million Molnupiravir tablets

Cambodia purchases 4 million Molnupiravir tablets

Cambodia has arranged purchase of four million Molnupiravir pills – which is enough to treat 100,000 Covid-19 patients – even though the current rate of daily infections in Cambodia remains low.

The medicine will be distributed to state hospitals, pharmacies and private clinics, according to the Samdech Techo Voluntary Youth Doctor Association (TYDA), an organisation that has been heavily involved with treating Covid-19 patients.

In a Facebook Post on December 3, TYDA said its deputy chairman of the board Pich Chanmony – who is also a part of the government working group in charge of research on medicine and medical equipment to combat Covid-19 – signed a purchase contract to buy Molnupiravir from the US-based manufacturer, the pharmaceutical giant Merck.

TYDA stated that the new antiviral drug for use in treating Covid-19 was an important safeguard to help patients at risk of serious illness, which is why the Cambodian government purchased enough doses to treat 100,000 people.

“It’s good news for Cambodia,” said Pich Chanmony on Facebook.

Hun Sen announced the purchase of Molnupiravir on November 1, with a total cost of about $2.5 million. Phnom Penh Post